Examkin

Soru

Zorluk: OrtaPharmacologic Interventions

A 58-year-old woman is brought to the emergency department by her family due to progressively worsening shortness of breath, inability to lie flat, and generalized weakness over the past three days. She has a history of ischemic cardiomyopathy with a left ventricular ejection fraction of 25%. Her home medications include sacubitril-valsartan, carvedilol, spironolactone, and dapagliflozin. Temperature is 36.8°C (98.2°F), blood pressure is 86/56 mmHg, pulse is 112/min, and respiratory rate is 24/min. Oxygen saturation is 88% on room air. The patient appears lethargic. Extremities are cool to the touch with faint peripheral pulses and 2+ pitting edema up to the knees. Jugular venous pulsation is visible at the angle of the mandible while sitting upright. Chest auscultation reveals diffuse bilateral crackles extending to the mid-lung fields. Laboratory studies show:

TestResult
Sodium132 mEq/L
Potassium4.2 mEq/L
Blood urea nitrogen45 mg/dL
Creatinine2.3 mg/dL (baseline 1.0 mg/dL)
Lactate3.8 mmol/L

An electrocardiogram shows sinus tachycardia with a left bundle branch block, unchanged from prior tracings. Which of the following is the most appropriate initial pharmacologic intervention for this patient?

  1. Intravenous dobutamineCevap
  2. B
    Intravenous furosemide
  3. C
    Intravenous 0.9% sodium chloride
  4. D
    Intravenous nitroglycerin
  5. E
    Intravenous metoprolol

Cevap

The most appropriate initial pharmacologic intervention is an intravenous inotropic agent, such as dobutamine.
This patient is presenting with acute decompensated heart failure (ADHF) characterized by volume overload ('wet') and poor end-organ perfusion ('cold'). Her poor perfusion is evidenced by hypotension, cool extremities, altered mentation, elevated lactate, and acute kidney injury. This hemodynamic profile represents cardiogenic shock. The most appropriate initial intervention is the administration of an intravenous inotropic agent, such as dobutamine. Dobutamine is a beta-1 adrenergic agonist that increases myocardial contractility, thereby increasing cardiac output and restoring perfusion to critical organs. Once hemodynamic stability and adequate perfusion are established, targeted volume removal with diuretics can be safely pursued.

Adım Adım Çözüm

1
Assess the patient's perfusion status based on clinical signs and laboratory values.
The patient has cool extremities, lethargy, hypotension, elevated lactate, and acute kidney injury.
These findings indicate poor end-organ perfusion, classifying her as 'cold' (cardiogenic shock).
2
Assess the patient's volume status.
The patient has orthopnea, jugular venous distention, pulmonary crackles, and peripheral edema.
These findings indicate severe volume overload, classifying her as 'wet'.
3
Determine the optimal pharmacologic strategy for 'cold and wet' acute decompensated heart failure.
Initial therapy must focus on improving cardiac output and maintaining blood pressure using inotropic agents.
Without inotropic support, attempting diuresis or vasodilation will further compromise perfusion and worsen the shock state.

Anahtar Kavram

Patients with 'cold and wet' acute decompensated heart failure (cardiogenic shock) require prompt initiation of inotropic support (e.g., dobutamine) to improve cardiac output and end-organ perfusion prior to aggressive diuresis.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru